Disease: Stage IV Cutaneous Melanoma AJCC v6 and v7 ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C4520732
Disease: Stage IV Cutaneous Melanoma AJCC v6 and v7
Stage IV Cutaneous Melanoma AJCC v6 and v7 		0.020 Biomarker disease BEFREE Baseline tumour <sup>18</sup>F-FDG uptake in stage IV melanoma is heterogeneous, independent of mutational status and cannot be fully explained by LDH levels. 30460579 2018
CUI: C4520732
Disease: Stage IV Cutaneous Melanoma AJCC v6 and v7
Stage IV Cutaneous Melanoma AJCC v6 and v7 		0.020 Biomarker disease BEFREE Our study indicates that whole-body 18F-FDG-PET might be able to reliably identify complete responders to PD1-therapy as early as two weeks after therapy initiation in stage IV melanoma patients. 28831583 2018